ACCL1633 - The Effectiveness of Lactobacillus plantarum (LBP, IND# 17339) in Preventing Acute Graft-versus-Host Disease (GvHD) in Children undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)

Contact:

NCT Number:

Protocol:

AAAS0470

Study Status:

Active/Enrolling

Population:

Pediatrics/Adult

Phase:

III

This randomized clinical trial is examining how well Lactobacillus plantarum works in preventing acute graft versus host disease in children who are undergoing stem cell transplant. Lactobacillus plantarum may help prevent the development of gastrointestinal graft versus host disease in children, adolescents, and young adults undergoing donor stem cell transplant.

Are you Eligible? (Inclusion Criteria)

  • Between 2 and 25 years of age
  • Receiving an stem cell transplant from a donor
  • No previous history of stem cell transplant or cellular therapy
  • Patients must also meet all other eligibility criteria as outlined in the study

Specialty Area(s)

Blood and Marrow Stem Cell Transplantation

Principal Investigator

Trial Location(s)

CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032